Fulvestrant 500mg With Exemestane Endocrine Therapy for Postmenopausal Advanced Breast Cancer Patients
Clinical trial NCT02646735 · UNKNOWN
Trial details
- NCT number
- NCT02646735
- Sponsor
- Chinese Academy of Medical Sciences
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-01
- Primary completion
- 2019-12-01
- Enrollment
- 148
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.